Cryptosporidiosis Therapeutics Pipeline AnalysisA Story by Manish KumarCryptosporidiosis is a severe form of illness caused by parasites of various Cryptosporidium species.Cryptosporidiosis is a severe
form of illness caused by parasites of various Cryptosporidium species. A person
can be infected by parasites by having contaminated food and water or coming in
contact with contaminated places. Some of the symptoms observed in
people with cryptosporidiosis are fever, nausea, vomiting, stomach pain, and
weight loss. People with weakened immune system, acquired immunodeficiency
syndrome (AIDS), cancer, or who have undergone a transplant are more likely to
develop cryptosporidiosis. Some of the complications associated with cryptosporidiosis are severe dehydration, inflammation of the bile duct, and malnutrition. This disease can be treated by fluid replacement therapy, anti-retroviral therapy, anti-motility agents, and anti-parasitic drugs. ioGenetics Inc. is in the process of developing DBAF201 for the treatment of cryptosporidiosis. Other than this Romark Laboratories L.C. is also involved in the cryptosporidiosis pipeline. Download the research study at: www.pharmaproff.com/request-sample/1058 © 2019 Manish KumarAuthor's Note
|
Stats
33 Views
Added on May 21, 2019 Last Updated on May 21, 2019 Tags: Cryptosporidiosis Therapeutics, Health, Cryptosporidiosis Therapeutics c, Cryptosporidiosis Therapeutics p Author
|